INTRODUCTION

Mohanakrishnan Sathyamoorthy, M.D., FACC, Dr. Mo as he is known, is an invasive cardiologist in practice in Fort Worth with scientific expertise in thrombosis and the pharmacology of blood thinning therapeutics.  Dr. Mo founded Consultants in Cardiovascular Medicine and Science - Fort Worth, PLLC dBA " Dr. Mo Heart", and opened its doors on January 1, 2021.  Dr. Mo has done this to enhance his ability to care for patients, create an infrastructure for clinical research to help his patients, and to oversee the development of a practice culture of excellence predicated on kindness, humility, and respect for all.  Dr. Mo started in practice with Vanderbilt Heart in 2007, moved to Fort Worth and practiced within two other groups from 2009 to the end of 2020 prior to establishing this exciting practice.

Dr. Mo was appointed Professor and name Founding Chair of the Department of Internal Medicine at the TCU and UNTHSC School of Medicine in 2018. Dr. Mo has been a long time physician leader at Baylor Scott and White All Saints, where he completed extended terms as the Chief of Staff, Vice Chief of Staff, and the Chief of the Cardiovascular Division - all from 2013 to 2020. In 2015, he was appointed as the first Medical Director of Cardiology for the newly formed Baylor Heart and Vascular Hospital Fort Worth, continues in this position, and has helped oversee leadership of this program that has experienced enormous growth while bringing many firsts in advanced cardiac care to Fort Worth. Dr. Sathyamoorthy serves his patients through a comprehensive cardiology practice, and specializes in the diagnosis and management of complex cardiovascular disorders. Dr. Sathyamoorthy has been featured routinely as a guest cardiologist on numerous media outlets in the Dallas-Fort Worth region. He, his wife Heather, the center of their lives - their two young children, and their whippet-terrier Bo,  are proud to make their home in Fort Worth.  They enjoy a very active lifestyle together, support and enjoy the fine and performing arts, and are big fans of all things related to sports!

Dr. Sathyamoorthy earned his Bachelor of Science in Biomedical Engineering and Masters in Engineering from Johns Hopkins University, during which time he pursued research in finite element biomechanical modeling of the heart. Dr. Sathyamoorthy earned his M.D. with Distinction in Research from the SUNY Stony Brook School of Medicine, where he was honored at graduation with the Award for Outstanding Achievements in Research, and The Citizenship Award for Outstanding Contributions to the School of Medicine. During Medical School, he was selected as on of 15 NIH CRTP Research Scholars nationally at the National Institutes of Health, and trained on campus for more than a year in an internationally renowned functional genomics program. Dr. Sathyamoorthy completed ABIM Research Pathway training as a physician-scientist in Internal Medicine and Cardiovascular Medicine and was named a Harrison Scholar at Vanderbilt University. He subsequently served as Chief Fellow, during which time he was instrumental in CV Fellowship reorganization and ACGME re-accreditation of the fellowship.

Dr. Sathyamoorthy joined the full-time Faculty at Vanderbilt University as a physician-scientist, pursuing mentored NIH Individual F32 NRSA funded laboratory work in the molecular manipulation of fibrinolytic proteins in a prominent thrombosis laboratory. Dr. Sathyamoorthy prepared and taught the molecular and clinical pharmacology coursework in fibrinolytic, anti-platelet, and anticoagulant therapeutics in the School of Medicine, during his full time Faulty tenure (2007-2009), and at the request of course directors, continued teaching this course as an adjunct Faculty (2009 to 2014). He was the submitting Co-PI at Vanderbilt for the COAG Trial, which was selected as one of twelve centers nationwide for the first NIH funded multi-center pharmacogenetics trial.

At the TCU and UNTHSC School of Medicine, Dr. Sathyamoorthy leads and has recruited and developed an entirely new Faculty for the largest clinical department in the medical school.  He has advised the Dean on numerous initiatives crucial to the School, including the development of an academic infrastructure agreement with Baylor Scott and White All Saints Medical Center.  During this past year Dr. Sathyamoorthy established the Fort Worth Clinical Sciences Working Group for COVID-19.  He envisioned and recruited members to develop a research collaborative among physician/scientists in Fort Worth to create novel proposals to treat the sickest COVID-19 patients.  The group has developed (5) proposals to date, with the first at the FDA nearing stages for a new IND approval; if this materializes, it will enable initiation of the study across all hospitals in Fort Worth - a first for the city of Fort Worth.  Dr. Sathyamoorthy founded the Sathyamoorthy Lab in 2019 at the medical school, and has 6 current M.D. candidate advisees working on comparative biology projects related to thrombosis, cardiovascular physiology, and genomics.  

Dr. Sathyamoorthy has been key advisor to the Baylor Transplant Selection Committee for over a decade, advising this group on all cardiac matters related to recipient selection. He remains an active member of the Adjoint Faculty at Vanderbilt University, is published in the peer reviewed literature, and frequently gives invited lectures around the country and internationally in his areas of clinical and scientific expertise. He presented invited sessions at the 28th Annual Meeting of the Japanese Coronary Association in December 2014 in Tokyo, Japan and at the 44th Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery in 2015. Dr. Sathyamoorthy completed a multi-year, extended term as President of the American Heart Association Tarrant County Division of the North Texas AHA Chapter, and remains on this board. He served on the Advisory Board of the Fort Worth Opera though 2016, and is a current Board of Trustee Member for the Fort Worth Academy.  Furthermore, Dr. Mo has given his time to advise aspiring young physicians through a mentorship program that he developed, and recruited numerous other practicing physician leaders to serve as mentors  to help these students successfully gain admission to medical school.